Tempest Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Tempest Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q3 2024.
  • Tempest Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 25.8M shares, a 82.7% increase year-over-year.
  • Tempest Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 15.4M shares, a 33.5% increase from 2022.
  • Tempest Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 11.5M shares, a 205% increase from 2021.
  • Tempest Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 3.79M shares, a 710% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 25.8M +11.7M +82.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 22.5M +8.44M +59.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 22.2M +8.47M +61.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 15.4M +3.87M +33.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 14.1M +486K +3.56% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 14.1M +2.53M +21.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 13.8M +6.6M +92% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 11.5M +7.76M +205% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 13.6M +6.92M +103% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 11.6M +10.6M +1151% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 7.17M +6.66M +1312% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 3.79M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 6.72M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 925K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 507K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.